epigallocatechin gallate has been researched along with epidermal growth factor in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CF; Liang, YC; Lin, JK; Lin-shiau, SY | 1 |
| Dong, Z; Huang, C; Ma, W; Yang, CS | 1 |
| Chen, YC; Ho, CT; Liang, YC; Lin, JK; Lin, YL; Lin-Shiau, SY | 1 |
| Cobrinik, D; Liberto, M | 1 |
| Adachi, S; Andersen, OS; Ingolfsson, HI; Kopelovich, L; Maxfield, FR; Nagao, T; Weinstein, IB | 1 |
| Bode, AM; Cho, YY; Choi, HS; Dong, Z; Ermakova, S; He, Z; Li, M; Ma, WY; Tang, F; Yang, CS; Zhao, Q | 1 |
| Adachi, S; Joe, AK; Kozawa, O; Matsushima-Nishiwaki, R; Maxfield, FR; Moriwaki, H; Nagao, T; Shimizu, M; To, S; Weinstein, IB | 1 |
| Fan, B; Han, G; Wei, L; Zhang, J; Zhang, Y; Zhou, X; Zhou, Y | 1 |
| Chatterjee, A; Sen, T | 1 |
| Backer, JM; Backer, MV; Chinnaiyan, P | 1 |
| Bode, AM; Chang, X; Chen, H; Dong, Z; Kim, DJ; Kim, HG; Malakhova, M; Shim, JH; Yao, K | 1 |
| Fujita, K; Kawabata, T; Kozawa, O; Matsushima-Nishiwaki, R; Otsuka, T; Sakai, G; Tokuda, H | 1 |
| Oteiza, PI; Zhu, W | 1 |
| Gnanagurusamy, J; Krishnamoorthy, S; Muruganatham, B; Muthusami, S; Sabanayagam, R | 1 |
14 other study(ies) available for epigallocatechin gallate and epidermal growth factor
| Article | Year |
|---|---|
Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Division; DNA, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Humans; Ligands; Phosphotyrosine; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Tea; Tumor Cells, Cultured | 1997 |
Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
Topics: Animals; Anticarcinogenic Agents; Biflavonoids; Catechin; Cell Transformation, Neoplastic; Chemoprevention; Epidermal Growth Factor; Mice; Phosphorylation; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-jun; Signal Transduction; Tea; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation | 1997 |
Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
Topics: 3T3 Cells; Animals; Biflavonoids; Carcinoma, Squamous Cell; Catechin; Cell Division; Epidermal Growth Factor; ErbB Receptors; Gallic Acid; Growth Inhibitors; Humans; Laryngeal Neoplasms; Mice; Phenols; Phosphorylation; Platelet-Derived Growth Factor; Polyphenols; Protein Binding; Protein Processing, Post-Translational; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Tea; Tumor Cells, Cultured | 1999 |
Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Catechin; Cell Cycle; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Epidermal Growth Factor; Growth Substances; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Retinoblastoma Protein; Signal Transduction; Tea; Time Factors | 2000 |
The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Catechin; Cell Membrane; Cross-Linking Reagents; Detergents; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Fluorescent Dyes; HT29 Cells; Humans; Membrane Microdomains; Octoxynol; Signal Transduction | 2007 |
Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation.
Topics: Activating Transcription Factor 2; Adaptor Proteins, Signal Transducing; Animals; Antioxidants; Catechin; Cell Survival; Cell Transformation, Neoplastic; CREB-Binding Protein; Dose-Response Relationship, Drug; Epidermal Growth Factor; Glutathione Transferase; Kinetics; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Protein Structure, Tertiary; Recombinant Fusion Proteins; RNA, Small Interfering; STAT1 Transcription Factor; Time Factors; Transcription Factor AP-1 | 2008 |
(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells.
Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Colonic Neoplasms; Endosomes; Epidermal Growth Factor; ErbB Receptors; Humans; Phosphorylation; Ubiquitin | 2008 |
Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Topics: Animals; Breast Neoplasms; Catechin; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Microfilament Proteins; Neuropeptides; Phosphoproteins; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; RNA, Messenger; RNA, Small Interfering; Tea; Time Factors; Up-Regulation | 2009 |
Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Female; Fibronectins; Focal Adhesion Kinase 1; Gene Silencing; Humans; Integrin alpha5beta1; Matrix Metalloproteinase 9; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2011 |
Targeting the unfolded protein response in cancer therapy.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Line; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Chaperone BiP; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Heat-Shock Proteins; Humans; Neoplasms; Thapsigargin; Unfolded Protein Response | 2011 |
Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG).
Topics: Adenosine Triphosphate; Animals; Binding, Competitive; Catalytic Domain; Catechin; Cell Line; Cell Survival; Computational Biology; Drug Evaluation, Preclinical; Epidermal Growth Factor; Mice; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa | 2015 |
(-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
Topics: Animals; Catechin; Cell Line; Cell Movement; Chlorogenic Acid; Epidermal Growth Factor; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Osteoblasts; p38 Mitogen-Activated Protein Kinases | 2018 |
NADPH oxidase 1: A target in the capacity of dimeric ECG and EGCG procyanidins to inhibit colorectal cancer cell invasion.
Topics: Caco-2 Cells; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Electrocardiography; Epidermal Growth Factor; ErbB Receptors; Humans; Matrix Metalloproteinase 2; NADPH Oxidase 1; Neoplasm Invasiveness; Proanthocyanidins | 2023 |
EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
Topics: Catechin; Epidermal Growth Factor; Female; Humans; Matrix Metalloproteinase 2; Papillomavirus Infections; Tumor Microenvironment; Uterine Cervical Neoplasms | 2023 |